Summary
The biologic activities of three synthetic analogues of CCK-4 (Trp-Met-Asp-Phe-NH2) in which (i) the C-terminal residue Phe was N-methylated (peptide I); (ii) the C-terminal Phe residue was N-methylated and Ser is substituted for Met in position 2 (peptide II); (iii) Pro was substituted for Trp in position 1 and the C-terminal amino nitrogen was methylated (peptide III), have been described. Peptides I and II have been found to inhibit the release of both insulin and glucagon, while peptide III was found to be a potent releasing agent for insulin and an inhibitor for glucagon.
Similar content being viewed by others
References
Ahmad N., Sharma S. D., Rastogi A. K., Kidwai J. R., Mathur K. B.: Stimulation of insulin secretion by peptide analogous to the C-terminal tetrapeptide amide of cholecystokinin — Acta diabetol lat.21, 361, 1984.
Eagle H.: Amino acid metabolism in mammalian cell cultures — Science130, 432, 1959.
Feldman J. M., Chapman B.: Preparation of islets of Langerhans from rabbits and hamsters by collagenase digestion technique — Acta diabetol. lat.12, 208, 1975.
Hazzard W. R., Crockford P. M., Buchanan K. D., Vance J. E., Chen R., Williams R. H.: A double antibody immunoassay for glucagon — Diabetes17, 179, 1968.
Khalid P., Sharma S. D., Khan M. M., Rastogi A. K., Kidwai J. R., Mathur K. B.: Synthetic analogs of cholecystokinin terminal tetrapeptide that stimulate insulin but not glucagon release from pancreatic islets — Acta diabetol. lat.23, 239, 1986.
Lacy P. E., Kostianovsky M.: Method for the isolation of intact islets of Langerhans from the rat pancreas — Diabetes16, 35, 1967.
Morgan R. C., Lazarow A.: Immunoassay of insulin: two antibody system. Plasma insulin levels of normal, subdiabetic and diabetic rats — Diabetes12, 115, 1963.
Rehfeld J. R., Larsson L. I., Goltermann N. R., Schwartz T. W., Holst J. J., Jensen S. L., Morley J. S.: Neural regulation of pancreatic hormone secretion by the C-terminal tetrapeptide amide of CCK — Nature (Lond.)284, 33, 1980.
Verspohl E. J., Wunderle G., Ammon H. P. T.: Proglumide antagonizes cholecystokinin effects on plasma glucose and insulinin vivo — Europ. J. Pharmacol.152, 121, 1988.
Author information
Authors and Affiliations
Additional information
C.D.R.I. Communication no 4264.
Abbreviations for amino acids and peptide derivatives according to IUPAC-IUB Commission on Biochemical Nomenclature [Biochemistry (Wash.)11, 1726, 1972].
Rights and permissions
About this article
Cite this article
Khalid, P., Chaturvedi, S., Khan, M.M. et al. Effect of some novel synthetic analogues of CCK-4 on insulin and glucagon secretion. Acta diabet. lat 26, 203–209 (1989). https://doi.org/10.1007/BF02581386
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02581386